Biological aging functions as an information degradation process where cells lose the ability to read their original, healthy genetic data due to misplaced methylation patterns. AI accelerates the development of longevity treatments by virtually screening billions of chemical molecules to find those capable of resetting these epigenetic markers, a task that would otherwise take centuries. By using specific genes—OCT4, SOX2, and KLF4—to mimic embryonic development, researchers can effectively reverse cellular age in mice and monkeys, restoring function in tissues like the retina and brain. This approach treats age-related conditions, including Alzheimer’s and motor neuron diseases, by addressing the underlying loss of cellular identity rather than just symptoms. Current laboratory breakthroughs, including the growth of human brain tissue from stem cells, demonstrate that cellular de-aging is a viable, repeatable mechanism for extending healthspan.
Sign in to continue reading, translating and more.
Continue
